ACVIX | DFFVX | ACVIX / DFFVX | |
Total Expense Ratio | 0.88 | 0.29 | 303% |
Annual Report Gross Expense Ratio | 0.88 | 0.30 | 293% |
Fund Existence | 27 years | 26 years | - |
Gain YTD | -5.974 | 3.910 | -153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.09B | 13.3B | 31% |
Annual Yield % from dividends | 1.06 | 1.68 | 63% |
Returns for 1 year | -13.11 | 2.47 | -532% |
Returns for 3 years | 11.41 | 34.38 | 33% |
Returns for 5 years | 46.36 | 91.09 | 51% |
Returns for 10 years | 19.98 | 73.97 | 27% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMIF | 25.72 | 0.18 | +0.69% |
iShares Emerging Markets Infras ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
REGL | 83.39 | 0.29 | +0.35% |
ProShares S&P MidCap 400 Dividend Arst | |||
DHDG | 33.21 | 0.02 | +0.06% |
FT Vest U.S. Eq Qt 2.5 to 15 Buffr ETF | |||
RIV | 11.58 | -0.07 | -0.60% |
RiverNorth Opportunities Fund |